Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
Year: 2026
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Authors: Kenichi Harano, Takehiro Nakao, Shin Nishio, Takahiro Katsuda, Kazuto Tasaki, Kazuhiro Takehara, Takanori Yokoyama, Hideki Furuya, Kyoko Hongo, Masatoshi Asano, Takashi Ikeno, Masashi Wakabayashi, Akihiro Sato, Hitoshi Saito, Chiaki Mashima, Ryo Kamata, Akihiro Ohashi, Suguru Odajima, Hiroshi Tanabe, Tetsuro Taki, Yasuto Fujimoto, Hirohiko Miyake, Reiko Watanabe, Genichiro Ishii, Toru Mukohara
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
Award: G624729074
OpenAlex ID: W7171834525